Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-28

FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex's original application for a generic nasal spray combining azelastine hydrochloride with fluticasone propionate for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE HYDROCHLORIDE (azelastine hydrochloride)
  • Fluticasone propionate (Fluticasone propionate)

Snippet

ORIG AP for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE)